This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Complications following infusion, transfusion and therapeutic injection
ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
539 |
4. Check minimum number of eventsNone |
539 |
5. Include endpointsNone |
539 |
6. Filter based on genotype QC (FinnGen only) |
539 |
Control definitions (FinnGen only)
- Control exclude
- ST19_COMPLICATIO_SURGI_MEDICAL_CARE_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T8
- Name in latin
- Complicationes infusionis, transfusionis sive injectionis therapeuticae
Similar endpoints
↥List of similar endpoints to
Complications following infusion, transfusion and therapeutic injection
based on the number of shared cases.
Similar with more cases:
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 539 | 319 | 220 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.10 |
| Median age at first event (years) | 58.77 | 55.68 | 63.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 492
- Matched controls
- 4920
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T80.8
ICD-10 Finland
Other complications following infusion, transfusion and therapeutic injection
+∞
184.3
165
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
129.9
98.4
103
10
T80.2
ICD-10 Finland
Infections following infusion, transfusion and therapeutic injection
+∞
94.9
88
*
T80.1
ICD-10 Finland
Vascular complications following infusion, transfusion and therapeutic injection
+∞
86.0
80
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
46.1
77.0
94
25
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
+∞
72.7
68
*
T80.9
ICD-10 Finland
Unspecified complication following infusion, transfusion and therapeutic injection
+∞
64.0
60
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
302.9
54.3
54
*
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
26.6
44.0
61
26
H02AB02
ATC
dexamethasone; systemic
6.4
43.7
128
257
B01AB05
ATC
enoxaparin; parenteral
4.0
42.5
228
867
A04AA02
ATC
granisetron; systemic, transdermal
9.6
42.5
91
113
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
39.0
178
574
X59
ICD-10 Finland
Exposure to unspecified factor
4.5
35.4
147
427
T80.0
ICD-10 Finland
Air embolism following infusion, transfusion and therapeutic injection
+∞
34.8
33
*
JN4AD
NOMESCO Finland
Body CT examination
7.4
34.4
87
139
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
34.4
140
397
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
33.3
277
1403
N02AA05
ATC
oxycodone; systemic
4.4
30.3
124
349
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
113.8
30.0
32
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.6
29.6
56
54
B01AB10
ATC
tinzaparin; parenteral
6.6
29.5
80
140
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
+∞
28.4
27
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.5
28.2
162
607
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
79.8
27.1
30
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
27.0
218
1035
R50.9
ICD-10 Finland
Fever, unspecified
4.2
26.8
115
335
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
26.4
101
263
T80.4
ICD-10 Finland
Rh incompatibility reaction
+∞
26.3
25
*
JN4BD
NOMESCO Finland
Extensive body CT
4.7
26.2
97
244
N02AX02
ATC
tramadol; systemic, rectal
2.8
25.4
257
1391
XX3DW
NOMESCO Finland
Time consuming IT work
4.6
24.4
92
235
T81.9
ICD-10 Finland
Unspecified complication of procedure
+∞
24.2
23
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.3
23.8
54
72
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.2
23.7
66
119
C03CA01
ATC
furosemide; systemic
2.9
23.2
178
799
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
240.7
22.8
23
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
22.0
21
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.2
22.0
90
248
T80.6
ICD-10 Finland
Other serum reactions
229.7
21.8
22
*
N02BE01
ATC
paracetamol; systemic, rectal
3.7
21.7
443
3501
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.4
21.6
45
52
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.1
21.5
54
84
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
6.7
21.0
55
91
WZC30
NOMESCO Finland
Teaching
3.7
21.0
102
326
ZX120
NOMESCO Finland
Intravenous
4.4
20.8
81
212
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
218.8
20.7
21
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
20.4
100
321
T80.3
ICD-10 Finland
ABO incompatibility reaction
+∞
19.9
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.1
19.6
55
100
WW500
NOMESCO Finland
Blood transfusion
6.7
19.5
51
84
A02BC02
ATC
pantoprazole; systemic
2.4
19.0
342
2373
J01FF01
ATC
clindamycin; systemic
2.7
19.0
167
797
X58
ICD-10 Finland
Exposure to other specified factors
3.6
19.0
94
304
L03AA13
ATC
pegfilgrastim; parenteral
7.2
18.8
46
69
L01BC06
ATC
capecitabine; oral
7.9
18.7
43
59
J01MA12
ATC
levofloxacin; systemic
2.9
17.9
125
516
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
186.4
17.6
18
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
17.5
65
162
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
65.7
16.8
19
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
175.7
16.6
17
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.5
16.6
83
269
A46
ICD-10 Finland
Erysipelas
3.2
16.5
95
341
L03AA14
ATC
lipegfilgrastim; parenteral
10.9
16.4
31
30
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
12.2
16.2
29
25
ZX070
NOMESCO Finland
Intensity modified radiotherapy
12.2
16.2
29
25
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.3
15.7
29
27
D70.82
ICD-10 Finland
Drug-induced neutropenia
14.4
15.7
26
19
J01MA02
ATC
ciprofloxacin; systemic
2.2
15.3
208
1211
Z51.5
ICD-10 Finland
Palliative care
4.7
15.0
52
121
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
14.9
75
243
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.0
14.7
33
44
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
14.7
14
*
UJF32
NOMESCO Finland
Coloscopy
2.4
14.6
152
772
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
14.5
162
853
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
14.4
167
894
ZXA00
NOMESCO Finland
Right side
2.3
14.1
153
794
TQW11
NOMESCO Finland
Vacuum treatment of wound
13.2
14.0
24
19
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
13.9
94
375
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.4
13.9
42
84
AA1AD
NOMESCO Finland
CT of head and brain
2.4
13.8
136
671
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
13.7
62
185
J01DB01
ATC
cefalexin; oral
2.4
13.5
408
3294
130
Kela drug reimbursment
Malignant tumour
3.6
13.5
62
187
A04AA55
ATC
palonosetron, combinations; systemic
6.6
13.3
34
55
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.1
13.3
36
63
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.0
13.1
29
38
ZZA00
NOMESCO Finland
Split skin graft
8.0
13.1
29
38
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
29.3
13.0
17
6
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
13.0
79
294
R06.0
ICD-10 Finland
Dyspnoea
2.3
13.0
138
703
128
Kela drug reimbursment
Cancers of female genital organs
10.9
12.9
24
23
JN4CD
NOMESCO Finland
Very extensive body CT
5.5
12.9
38
74
H02AB06
ATC
prednisolone; systemic
2.0
12.8
244
1604
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
12.8
68
230
R4110
NOMESCO Finland
Physiotherapy
2.3
12.7
143
750
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.1
12.7
50
132
Y60
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
71.7
12.6
14
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
12.5
82
319
N02AJ06
ATC
codeine and paracetamol; systemic
2.1
12.5
193
1162
WX402
NOMESCO Finland
General anaesthesia
2.6
12.0
98
434
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
12.0
227
1473
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
12.0
59
188
C07AB07
ATC
bisoprolol; oral
2.0
11.9
239
1585
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.8
11.9
80
316
B01AA03
ATC
warfarin; systemic
2.4
11.9
111
527
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.0
11.8
26
34
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.9
11.7
38
83
S18
ICPC
Laceration/cut
2.0
11.6
211
1346
R07.4
ICD-10 Finland
Chest pain, unspecified
2.2
11.6
146
799
A41.9
ICD-10 Finland
Sepsis, unspecified
6.3
11.5
30
50
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.3
11.5
30
50
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.0
11.5
46
123
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
5.0
11.4
36
76
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.9
11.4
21
20
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
11.3
39
91
A11CC03
ATC
alfacalcidol; systemic
6.7
11.3
28
44
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
11.1
119
602
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
5.5
11.1
32
61
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
11.1
130
688
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
10.9
101
476
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.6
10.8
49
147
WX110
NOMESCO Finland
Local anesthesy
1.9
10.8
337
2599
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.1
10.7
60
209
UKC02
NOMESCO Finland
Cystoscopy
2.5
10.7
90
404
WX002
NOMESCO Finland
Sedation and analgesia
2.3
10.7
108
531
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
10.6
92
419
HA1AA
NOMESCO Finland
X-ray mammography
3.4
10.6
51
160
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.8
10.6
35
78
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
10.5
54
178
SPAT1255
SPAT
Intravenous administration of medicine
3.6
10.5
47
139
X57
ICD-10 Finland
Unspecified privation
8.0
10.5
23
30
A04AA01
ATC
ondansetron; systemic, rectal
3.5
10.5
50
156
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
+∞
10.4
10
*
XW000
NOMESCO Finland
Bone marrow biopsy
4.4
10.4
37
89
N03AX16
ATC
pregabalin; oral
2.1
10.4
129
698
R11
ICD-10 Finland
Nausea and vomiting
3.3
10.3
53
175
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.2
10.2
24
35
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.7
10.2
25
39
A04AD12
ATC
aprepitant; systemic
7.0
10.0
24
36
TK800
NOMESCO Finland
Hemodialysis
7.0
10.0
24
36
J01DA01
ATC
[U] cefalexin; systemic
1.8
9.7
303
2290
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
9.7
168
1033
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
5.2
9.7
29
58
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.4
9.7
34
81
N03AX12
ATC
gabapentin; oral
2.4
9.6
86
398
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
9.6
180
1138
V03AE01
ATC
polystyrene sulfonate; oral
9.4
9.6
19
21
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
10.3
9.6
18
18
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.1
9.5
120
650
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.9
9.5
38
103
Y88.0
ICD-10 Finland
Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use
101.9
9.4
10
*
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
9.4
9
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
9.4
93
451
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
9.3
95
465
N05CF01
ATC
zopiclone; oral
1.9
9.3
164
1014
E86
ICD-10 Finland
Volume depletion
5.9
9.3
25
44
E0000UV
ATC
NA
1.9
9.3
197
1301
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
9.1
149
895
N18.0
ICD-10 Finland
End-stage renal disease
11.8
9.1
16
14
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.8
9.1
29
63
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.3
9.1
46
151
115
Kela drug reimbursment
Breast cancer
3.1
9.0
51
179
K56.7
ICD-10 Finland
Ileus, unspecified
7.7
9.0
20
27
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
19.0
9.0
13
7
L01CA04
ATC
vinorelbine; systemic
19.0
9.0
13
7
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
12.8
8.9
15
12
A41.8
ICD-10 Finland
Other specified sepsis
7.4
8.8
20
28
SPAT1263
SPAT
Sampling
1.8
8.8
217
1499
JAH00
NOMESCO Finland
Laparotomy
5.3
8.6
25
49
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
28.1
8.5
11
*
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
91.6
8.4
9
*
M79.6
ICD-10 Finland
Pain in limb
1.8
8.4
174
1130
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.4
8.4
21
34
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
8.4
93
473
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.6
8.4
28
64
WX892
NOMESCO Finland
Monitored bed care
2.9
8.4
50
184
R60.0
ICD-10 Finland
Localized oedema
2.6
8.4
63
266
T80.5
ICD-10 Finland
Anaphylactic shock due to serum
+∞
8.4
8
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.7
8.3
35
99
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.9
8.3
51
188
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
8.2
39
122
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.7
8.2
18
24
N06AX11
ATC
mirtazapine; oral
1.9
8.2
157
992
I50.9
ICD-10 Finland
Heart failure, unspecified
2.5
8.2
67
294
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.9
8.2
48
174
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.4
8.1
28
66
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
4.4
8.1
28
66
B99
ICD-10 Finland
Other and unspecified infectious diseases
7.4
8.0
18
25
L17
ICPC
Foot/toe symptom/complaint
1.9
8.0
125
734
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.7
8.0
26
58
B01AC04
ATC
clopidogrel; oral
2.2
8.0
82
403
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.8
8.0
19
29
JFB00
NOMESCO Finland
Partial resection of small intestine
8.0
7.9
17
22
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
7.9
49
182
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
13.3
7.9
13
10
A12AA04
ATC
calcium carbonate; oral
7.1
7.8
18
26
R52.9
ICD-10 Finland
Pain, unspecified
2.9
7.8
48
178
G56.4
ICD-10 Finland
Causalgia
45.7
7.7
9
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
45.7
7.7
9
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
45.7
7.7
9
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.6
7.7
17
23
N05BA01
ATC
diazepam; systemic, rectal
2.3
7.7
72
340
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.8
7.7
48
180
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
3.1
7.7
43
149
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
7.7
85
434
S97
ICPC
Chronic ulcer skin
3.4
7.6
35
107
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
12.1
7.6
13
11
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
12.1
7.6
13
11
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
12.1
7.6
13
11
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
5.6
7.6
21
39
H02AB09
ATC
hydrocortisone; systemic
5.6
7.6
21
39
L04AX01
ATC
azathioprine; systemic
4.3
7.6
27
66
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
7.6
137
844
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
10.3
7.6
14
14
L03AA02
ATC
filgrastim; parenteral
5.0
7.5
23
48
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
5.2
7.5
22
44
R18
ICD-10 Finland
Ascites
6.6
7.5
18
28
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
7.5
42
147
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
7.5
89
468
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.3
7.4
36
115
J01XX08
ATC
linezolid; systemic
81.3
7.4
8
*
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
81.3
7.4
8
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.1
7.3
38
128
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
+∞
7.3
7
*
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
4.1
7.3
27
69
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
16.0
7.3
11
7
TPX15
NOMESCO Finland
Removal of vascular injection port
16.0
7.3
11
7
ZXA05
NOMESCO Finland
Left side
1.9
7.2
125
756
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
7.2
68
321
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.1
7.1
15
19
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
7.1
242
1803
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
6.2
7.1
18
30
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
7.1
50
204
A06AH03
ATC
naloxegol; oral
12.3
7.1
12
10
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
9.0
7.1
14
16
A07AA09
ATC
vancomycin; oral
9.0
7.1
14
16
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
7.1
108
626
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
10.2
7.1
13
13
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
10.2
7.1
13
13
WW200
NOMESCO Finland
Immunization
4.4
7.0
24
57
M04AA01
ATC
allopurinol; systemic
2.3
7.0
67
319
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.7
7.0
22
48
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
7.0
41
150
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
14.0
6.9
11
8
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.7
6.9
28
78
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.9
186
1293
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.3
6.9
64
302
A02BC01
ATC
omeprazole; systemic
1.8
6.9
137
868
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
9.5
6.8
13
14
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.8
6.8
18
32
N05BA04
ATC
oxazepam; oral
1.8
6.8
122
749
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
17.0
6.8
10
6
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
6.8
32
101
N06AX21
ATC
duloxetine; oral
2.4
6.7
56
250
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
6.7
102
589
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.9
6.7
26
70
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.6
6.7
18
33
D07AA02
ATC
hydrocortisone; topical
2.1
6.7
72
364
SPAT1262
SPAT
Handing over of treatment supplies
2.0
6.7
91
506
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
6.6
73
369
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
10.2
6.6
12
12
SPAT1301
SPAT
No procedures
1.7
6.6
157
1051
J01CA04
ATC
amoxicillin; systemic
1.7
6.5
383
3286
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.3
6.5
16
26
A02BC05
ATC
esomeprazole; systemic
1.7
6.5
194
1386
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
6.5
100
580
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
70.7
6.4
7
*
I50.0
ICD-10 Finland
Congestive heart failure
2.8
6.4
41
157
R51.80
ICD-10 Finland
Headache
2.1
6.4
68
342
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.1
6.4
23
58
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
8.3
6.4
13
16
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
6.1
6.3
16
27
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
6.3
34
118
JFF10
NOMESCO Finland
Loop enterostomy
11.2
6.3
11
10
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
6.3
48
205
J01MA14
ATC
moxifloxacin; systemic
2.5
6.3
48
205
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
6.3
25
69
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
T84.1
ICD-10 Finland
Mechanical complication of internal fixation device of bones of limb
+∞
6.3
6
*
T88.8
ICD-10 Finland
Other specified complications of surgical and medical care, not elsewhere classified
+∞
6.3
6
*
NFU00
NOMESCO Finland
Removal of partial prosthesis from hip joint, other or unspecified
+∞
6.3
6
*
A28
ICPC
Limited function/disability NOS
2.1
6.3
71
366
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
7.2
6.3
14
20
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
5.1
6.2
18
36
J05AB11
ATC
valaciclovir; oral
2.2
6.2
66
329
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.2
6.2
30
97
ZX080
NOMESCO Finland
Image guided radiotherapy
4.8
6.2
19
41
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
6.1
72
375
J01AA02
ATC
doxycycline; systemic
1.7
6.1
359
3040
JKA20
NOMESCO Finland
Cholecystectomy
5.0
6.1
18
37
WX882
NOMESCO Finland
High dependency care
3.7
6.1
25
71
NB6AA
NOMESCO Finland
Humerus X-ray examination
6.2
6.0
15
25
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
5.7
6.0
16
29
Z31.5
ICD-10 Finland
Genetic counselling
3.2
6.0
30
99
A06AD11
ATC
lactulose; oral
2.1
6.0
73
385
I25.2
ICD-10 Finland
Old myocardial infarction
2.6
6.0
40
159
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
177
635
3.66
40.76
8.9
3.1
0.8
0.8
mmol/l
1.81
172
591
383
2225
3.49
39.25
12.7
5.7
10.8
12.0
umol/l
0.89
374
2097
59
89
7.32
38.16
1.8
1.2
—
—
—
0
0
133
424
3.84
36.09
5.3
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
61
105
6.42
34.77
8.7
2.9
0.3
0.3
u/ml
0.19
38
55
359
2096
3.13
34.64
15.4
6.0
1.2
1.2
mmol/l
1.79
270
1782
395
2476
3.23
32.81
21.9
8.4
4.1
4.0
e9/l
0.29
370
2164
49
72
7.39
32.35
7.1
7.2
384.2
205.6
iu/ml
—
10
13
128
428
3.61
32.06
7.1
4.2
242.7
257.8
u/l
0.32
119
405
311
1770
2.79
29.79
10.9
4.3
33.4
35.8
g/l
8.65
298
1659
205
942
2.90
29.69
3.4
1.7
1.4
1.1
mg/l
0.77
168
718
330
1943
2.80
29.46
14.4
5.3
1.2
1.2
mmol/l
1.83
315
1755
94
274
3.94
28.60
2.3
1.4
—
—
—
0
0
385
2487
2.92
28.17
10.3
4.2
6.7
6.7
mmol/l
0.21
373
2302
160
663
3.01
27.73
2.4
1.9
—
—
—
0
0
51
99
5.59
25.55
1.9
1.8
—
—
—
0
0
282
1611
2.57
25.53
5.5
3.5
35.4
40.1
ng/l
0.27
217
1102
68
169
4.46
25.51
2.7
2.0
1.7
1.5
g/l
0.57
61
150
132
523
3.02
24.47
16.2
4.8
1.1
1.1
mmol/l
0.28
127
477
35
48
7.73
24.44
1.6
1.3
—
—
—
0
0
24
20
12.51
23.99
4.2
2.8
9.0
15.5
%
0.93
12
13
64
163
4.32
23.22
2.9
1.9
1.8
1.9
ug/l
0.03
59
144
43
78
5.90
23.10
1.7
1.9
—
—
—
0
0
240
1330
2.45
22.42
4.2
2.2
51.3
56.7
u/l
1.84
231
1226
23
21
11.40
21.68
5.0
2.8
—
—
—
0
0
324
2074
2.41
21.57
11.8
5.6
26.6
28.8
%
2.53
314
1938
101
367
3.16
21.56
3.2
2.2
0.2
0.2
g/l
0.50
93
344
320
2056
2.37
20.85
11.2
5.4
57.4
56.3
%
0.76
308
1931
48
106
4.87
20.74
1.9
1.8
—
—
—
0
0
115
470
2.84
19.81
2.4
1.8
—
—
—
0
0
131
582
2.65
19.13
4.2
2.2
2.3
2.3
g/l
0.85
125
536
125
545
2.68
18.94
4.4
2.2
23.4
23.0
%
0.11
114
467
242
1429
2.26
18.63
6.6
3.1
2.3
2.4
mmol/l
2.61
219
1246
112
467
2.77
18.48
2.2
1.8
—
—
—
0
0
298
1920
2.23
18.45
7.2
3.6
—
—
—
0
0
25
32
8.14
18.42
1.4
1.2
—
—
—
0
0
192
1035
2.33
18.32
3.1
2.0
3.1
3.0
mg/l
0.16
164
882
136
632
2.54
18.01
4.3
2.2
12.1
13.6
umol/l
1.75
130
580
36
70
5.44
17.93
1.8
1.8
—
—
—
0
0
255
1559
2.21
17.80
4.3
3.0
—
—
—
0
0
31
54
6.03
17.30
1.8
1.8
—
—
—
0
0
216
1252
2.21
17.05
2.8
2.1
167.1
293.9
u/l
0.86
209
1177
90
348
2.90
17.03
9.7
6.0
1.3
1.4
mmol/l
0.14
84
331
388
2834
2.32
17.02
6.7
4.2
5.0
3362.9
e6/l
—
5
54
33
63
5.51
16.76
2.1
1.7
—
—
—
0
0
41
95
4.59
16.69
3.1
1.8
—
—
—
0
0
223
1327
2.16
16.31
4.0
3.0
209.6
123.3
e6/l
0.31
192
1032
103
438
2.67
16.22
10.1
6.3
1.4
1.2
mmol/l
0.15
91
346
202
1190
2.12
14.87
3.9
2.9
0.3
0.4
e6/l
0.87
164
897
98
425
2.60
14.76
5.6
4.0
6.2
20.3
ug/l
0.78
87
355
31
63
5.16
14.69
1.8
1.7
—
—
—
0
0
428
3348
2.35
14.60
17.6
6.8
85.3
79.6
u/l
1.39
418
3123
29
57
5.32
14.26
1.8
1.8
—
—
—
0
0
202
1220
2.05
13.67
3.6
3.0
1786.3
1070.5
ng/l
1.05
179
1027
26
48
5.64
13.66
2.0
1.9
—
—
—
0
0
35
84
4.39
13.62
2.5
2.4
16.4
16.0
%
0.16
15
37
70
268
2.85
13.38
7.4
4.7
1.7
1.9
mmol/l
0.15
58
206
67
256
2.85
12.84
2.0
1.4
—
—
—
0
0
38
104
3.86
12.43
5.4
2.6
25.4
25.2
mmol/l
0.08
32
88
222
1423
1.95
12.41
4.9
3.2
41.2
32.5
u/l
0.54
211
1354
14
14
10.24
12.28
2.7
6.4
102.8
94.5
%
0.31
14
14
261
1773
1.92
12.20
3.4
2.3
76.4
76.8
nmol/l
0.09
242
1573
39
114
3.61
11.61
1.5
1.3
232.7
306.1
ug/g
1.16
23
66
85
386
2.43
11.48
10.9
3.6
1.9
2.1
mmol/l
0.36
72
300
42
132
3.37
11.20
2.7
3.1
—
—
—
0
0
34
93
3.83
11.13
1.4
1.4
—
—
—
0
0
30
75
4.18
11.09
4.8
3.6
56.2
58.2
%
0.27
30
75
102
512
2.22
10.90
19.4
20.2
1.6
1.2
inr
0.87
16
73
27
63
4.46
10.88
2.7
3.7
1.3
1.1
%
0.12
22
53
14
5
28.68
10.77
3.3
1.8
—
—
—
0
0
71
308
2.50
10.55
5.8
3.0
246.6
196.0
ng/l
0.44
66
279
29
74
4.08
10.43
4.2
3.1
3.9
4.4
e9/l
0.45
29
74
75
337
2.42
10.33
2.8
2.3
4.9
6.8
ug/l
0.74
65
296
70
312
2.43
9.80
8.0
3.5
108.2
72.1
ng/l
1.94
64
275
158
969
1.89
9.63
5.1
2.0
—
—
—
0
0
259
1850
1.77
9.53
4.9
2.6
219.4
118.4
ug/l
4.23
235
1699
18
33
5.61
9.51
2.2
1.9
—
—
—
0
0
179
1152
1.83
9.32
5.7
3.8
0.0
0.0
estimate
0.50
90
400
289
2140
1.76
9.30
6.6
4.7
0.0
0.0
estimate
0.00
92
405
134
795
1.91
8.96
5.9
3.5
1856.4
387.5
ng/l
0.51
105
606
35
113
3.24
8.96
1.4
1.2
—
—
—
0
0
290
2166
1.73
8.90
5.2
3.5
0.0
0.0
estimate
0.50
86
392
49
193
2.69
8.84
11.1
8.4
24.7
24.5
mmol/l
0.19
43
178
32
99
3.37
8.76
1.2
1.3
—
—
—
0
0
22
52
4.37
8.73
1.8
1.9
—
—
—
0
0
128
761
1.89
8.46
2.2
1.7
1362.5
1191.1
nmol/l
1.10
102
577
284
2128
1.71
8.46
5.2
3.5
0.0
0.0
estimate
0.00
89
407
14
23
6.22
8.22
2.3
2.0
—
—
—
0
0
90
479
2.06
8.16
6.4
2.8
6.9
7.7
umol/l
0.36
84
423
127
762
1.87
8.13
7.1
2.7
2.5
2.4
mmol/l
0.98
114
675
50
208
2.55
8.09
11.5
3.9
23.8
24.2
mmol/l
0.48
44
188
143
892
1.82
8.08
1.8
1.7
435.5
438.4
pmol/l
0.05
119
744
15
27
5.69
8.06
2.2
1.9
—
—
—
0
0
14
24
5.96
7.89
2.3
1.9
—
—
—
0
0
29
91
3.31
7.78
2.3
2.1
124.8
130.2
g/l
0.45
19
66
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
12
8
15.30
7.74
1.2
2.4
201.1
130.0
%
—
12
8
17
36
4.84
7.69
1.4
2.0
—
—
—
0
0
12
18
6.80
7.63
3.1
2.7
2429.3
840.7
u/ml
0.56
12
18
10
12
8.47
7.60
1.7
1.2
—
—
—
0
0
155
1009
1.75
7.51
1.8
1.5
20.8
20.7
nmol/l
0.02
139
845
19
46
4.24
7.33
1.8
2.1
—
—
—
0
0
229
1666
1.65
7.29
5.6
3.6
—
—
—
0
0
29
95
3.17
7.27
1.8
1.3
—
—
—
0
0
26
81
3.32
7.06
1.9
1.3
—
—
—
0
0
16
36
4.55
6.75
1.2
1.2
—
—
—
0
0
34
130
2.72
6.52
1.4
1.4
0.3
0.1
iu/ml
0.31
12
24
386
3248
1.66
6.50
6.0
4.0
16.5
12.1
mm/h
4.72
358
2984
161
1105
1.65
6.25
4.1
2.6
2523.3
8994.8
umol/l
1.63
149
947
24
78
3.17
6.11
2.0
1.3
248.9
281.4
u/ml
0.22
17
44
14
31
4.61
6.01
3.6
2.2
590.6
559.3
e6/l
—
7
12
50
241
2.18
5.84
2.0
1.6
—
—
—
0
0
70
387
1.93
5.66
2.5
2.3
38.6
34.4
u/l
0.18
55
333
10
17
5.97
5.64
4.5
1.7
—
—
—
0
0
10
17
5.97
5.64
4.7
1.7
—
—
—
0
0
37
161
2.39
5.48
2.6
1.9
—
—
—
0
0
345
2883
1.55
5.44
5.6
2.9
67.8
44.8
u/l
3.06
323
2676
8
5
16.22
5.42
1.0
1.0
—
—
—
0
0
14
34
4.20
5.39
6.4
2.1
—
—
—
0
0
47
229
2.15
5.36
9.1
2.7
71.8
49.3
u/ml
0.33
47
219
10
18
5.64
5.34
1.0
1.7
—
—
—
0
0
16
44
3.72
5.24
1.4
1.8
—
—
—
0
0
16
44
3.72
5.24
1.4
1.8
—
—
—
0
0
16
44
3.72
5.24
1.4
1.8
—
—
—
0
0
23
81
2.92
5.15
2.1
1.4
19853.8
10775.0
e6/l
0.83
18
65
8
6
13.51
5.09
2.4
5.7
—
—
—
0
0
17
50
3.48
5.06
2.8
1.7
33.8
32.3
pg
0.81
17
50
34
148
2.38
5.05
2.7
1.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
7
11.58
4.79
1.0
1.0
99.3
115.0
%
—
8
7
10
20
5.08
4.79
1.4
1.3
—
—
—
0
0
27
108
2.58
4.78
1.3
1.4
—
—
—
0
0
479
4383
1.83
4.75
40.9
12.4
27.6
22.6
mg/l
2.26
439
3413
16
48
3.40
4.64
1.6
1.3
—
—
—
0
0
217
1697
1.47
4.40
2.5
1.9
90.2
95.7
pmol/l
1.00
127
875
105
703
1.61
4.36
3.2
2.8
5.0
2.3
e6/l
0.92
64
399
28
120
2.41
4.32
2.4
2.3
556.7
1024.7
u/l
0.31
11
47
10
22
4.61
4.32
1.5
1.3
—
—
—
0
0
10
22
4.61
4.32
1.5
1.3
—
—
—
0
0
33
155
2.20
4.15
1.7
1.4
0.3
0.2
g/l
0.61
28
147
38
189
2.09
4.14
8.8
5.5
24.4
24.9
mmol/l
0.61
38
184
27
117
2.38
4.08
8.9
3.9
1.6
1.5
mg/l
0.36
22
107
26
111
2.41
4.06
1.2
1.1
—
—
—
0
0
16
54
3.02
3.88
1.6
1.1
5.4
1.6
u/ml
—
7
16
24
102
2.42
3.79
1.7
1.3
—
—
—
0
0
16
55
2.97
3.76
1.2
1.2
—
—
—
0
0
14
46
3.10
3.55
1.2
1.5
0.3
0.3
nmol/l
—
8
35
6
6
10.09
3.50
1.2
1.0
95.2
110.0
%
—
6
6
7
10
7.07
3.37
1.0
1.1
—
—
—
0
0
8
14
5.78
3.35
1.5
2.1
135.6
61.0
ug/l
—
8
14
103
732
1.50
3.26
3.0
2.6
1.5
1.1
e6/l
0.32
62
424
10
28
3.62
3.21
1.7
1.4
—
—
—
0
0
9
20
4.56
3.12
1.0
1.1
—
—
—
0
0
7
12
5.89
3.03
1.4
2.1
—
—
—
0
0
5
5
10.08
2.98
1.4
1.2
—
—
—
0
0
30
156
1.98
2.96
3.8
3.5
374.0
388.7
u/ml
0.02
25
134
14
52
2.74
2.91
1.2
1.1
—
—
—
0
0
16
64
2.55
2.89
1.3
1.3
—
—
—
0
0
15
58
2.63
2.89
1.6
1.4
—
—
—
0
0
13
47
2.81
2.83
1.2
1.1
—
—
—
0
0
15
59
2.59
2.81
1.6
1.4
—
—
—
0
0
15
59
2.59
2.81
1.6
1.4
—
—
—
0
0
5
6
8.40
2.75
4.2
1.8
480.6
3085.0
u/l
—
5
6
16
66
2.47
2.73
1.3
1.1
—
—
—
0
0
15
60
2.54
2.72
1.6
1.4
—
—
—
0
0
15
60
2.54
2.72
1.6
1.4
—
—
—
0
0
42
251
1.73
2.71
3.0
2.6
0.1
0.2
e6/l
0.90
42
243
19
87
2.23
2.60
1.7
1.4
—
—
—
0
0
19
87
2.23
2.60
1.7
1.4
—
—
—
0
0
8
20
4.04
2.57
1.5
1.3
—
—
—
0
0
8
20
4.04
2.57
1.0
1.2
—
—
—
0
0
8
20
4.04
2.57
1.5
1.3
—
—
—
0
0
5
7
7.20
2.55
1.0
1.0
—
—
—
0
0
7
17
4.16
2.36
2.7
4.8
—
—
—
0
0
402
3700
1.34
2.29
44.6
15.3
14.4
13.6
%
17.11
396
3628
11
41
2.72
2.29
1.0
1.1
—
—
—
0
0
6
13
4.65
2.27
1.0
1.1
—
—
—
0
0
6
13
4.65
2.27
2.0
1.2
—
—
—
0
0
6
13
4.65
2.27
8.8
3.5
29.8
28.9
umol/l
—
6
13
6
13
4.65
2.27
2.0
1.2
91.3
93.6
%
—
6
13
7
18
3.92
2.26
1.4
1.2
5.3
7.3
mmol/l
—
7
18
14
60
2.37
2.23
1.6
1.4
—
—
—
0
0
370
3373
1.31
2.21
4.8
3.9
15.0
14.8
pmol/l
1.23
330
3045
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
7
19
3.72
2.15
1.0
1.0
—
—
—
0
0
11
43
2.59
2.11
1.0
1.1
—
—
—
0
0
11
43
2.59
2.11
1.2
1.1
—
—
—
0
0
25
139
1.84
2.08
1.9
1.7
—
—
—
0
0
15
69
2.21
2.06
1.1
1.1
—
—
—
0
0
6
15
4.03
2.04
1.0
1.1
1764.3
1474.2
miu/ml
—
6
15
404
4301
0.76
2.02
5.1
4.4
1.4
1.5
mmol/l
3.84
368
3945
9
32
2.84
2.01
3.7
1.9
—
—
—
0
0
71
518
1.43
1.98
11.7
6.5
—
—
—
0
0
6
17
3.56
1.84
1.0
1.1
—
—
—
0
0
9
35
2.60
1.81
1.0
1.3
—
—
—
0
0
9
35
2.60
1.81
1.0
1.3
—
—
—
0
0
409
4331
0.77
1.80
5.2
4.4
4.4
4.7
mmol/l
3.72
378
3998
8
29
2.78
1.79
3.4
3.5
—
—
—
0
0
21
358
0.57
1.78
2.0
1.7
—
—
—
0
0
9
36
2.52
1.74
1.1
1.1
—
—
—
0
0
9
36
2.52
1.74
1.2
1.0
—
—
—
0
0
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
6
19
3.18
1.66
1.5
2.3
—
—
—
0
0
6
19
3.18
1.66
1.5
2.3
—
—
—
0
0
25
150
1.70
1.66
1.8
2.1
—
—
—
0
0
7
25
2.82
1.65
3.3
2.8
71.0
84.8
nmol/l
—
7
25
15
77
1.98
1.60
1.3
1.2
49.6
14.9
u/l
0.49
15
65
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
26
2.71
1.58
1.1
1.1
—
—
—
0
0
6
20
3.02
1.58
1.5
2.2
—
—
—
0
0
471
4506
1.36
1.58
41.8
14.3
139.1
139.8
mmol/l
7.20
465
4367
11
50
2.23
1.58
1.6
1.4
—
—
—
0
0
12
57
2.13
1.56
1.6
1.2
1.5
4.2
u/ml
—
6
25
393
4158
0.80
1.52
4.8
3.9
1.4
1.3
mmol/l
2.19
355
3791
25
156
1.63
1.46
1.4
2.4
4.2
3.9
g/l
0.93
19
114
25
156
1.63
1.46
1.4
2.4
—
—
—
0
0
420
4404
0.79
1.44
5.4
4.9
2.6
2.8
mmol/l
2.93
385
4035
89
713
1.30
1.40
1.2
1.3
24.6
10.3
u/ml
0.55
31
273
117
971
1.26
1.40
6.0
3.7
1.0
1.0
kg/l
0.27
20
148
471
4523
1.33
1.39
42.2
14.4
4.0
4.0
mmol/l
1.50
463
4379
99
809
1.27
1.34
1.6
1.5
—
—
—
0
0
155
1334
1.23
1.34
3.5
3.1
6.6
7.5
mmol/l
1.58
134
1106
5
18
2.79
1.28
1.4
2.1
—
—
—
0
0
45
331
1.39
1.25
6.2
2.5
57.9
68.3
ml/min/173m2
1.08
24
126
6
25
2.42
1.24
27.0
14.6
1400.5
1532.4
nmol/l
—
6
25
6
25
2.42
1.24
22.2
10.8
741.5
805.4
nmol/l
—
6
25
20
124
1.64
1.22
1.4
1.2
—
—
—
0
0
5
19
2.65
1.22
2.0
3.6
230.6
203.7
u/l
—
5
19
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
6
26
2.32
1.19
1.5
2.0
—
—
—
0
0
14
79
1.79
1.18
1.4
1.2
0.9
3.4
u/ml
—
5
33
298
2755
1.18
1.15
3.4
3.0
—
—
—
0
0
115
975
1.23
1.14
1.4
1.2
1.2
1.3
u/ml
0.10
35
255
91
756
1.25
1.09
1.3
1.3
16.1
35.4
iu/ml
3.48
27
238
7
32
2.20
1.08
2.7
1.3
—
—
—
0
0
7
33
2.14
1.06
2.7
3.3
—
—
—
0
0
18
114
1.60
1.04
1.6
2.5
0.0
0.0
g/l
0.00
18
105
11
60
1.85
1.03
2.2
2.6
105.0
105.8
mmol/l
0.31
11
60
11
60
1.85
1.03
2.2
2.6
4.0
4.0
mmol/l
0.04
11
60
482
4680
1.28
1.00
22.5
9.7
28.0
25.9
u/l
1.53
472
4505
18
116
1.57
0.97
1.6
2.5
0.0
0.0
g/l
0.00
18
106
62
500
1.27
0.96
2.9
1.6
1.5
1.5
%
0.01
56
441
9
52
1.74
0.92
3.9
3.6
—
—
—
0
0
20
136
1.49
0.87
1.3
1.4
166.6
267.1
miu/ml
—
5
60
145
1297
1.16
0.80
4.4
4.0
13.0
8.1
mg/mmol
0.67
99
800
12
75
1.61
0.75
1.8
1.4
—
—
—
0
0
18
125
1.46
0.73
1.6
2.5
0.0
0.0
g/l
0.50
18
115
5
25
2.01
0.73
1.6
1.1
—
—
—
0
0
17
117
1.47
0.72
2.5
2.5
272.2
79.4
ug/min
0.36
11
68
19
134
1.43
0.72
1.3
1.1
—
—
—
0
0
19
134
1.43
0.72
1.3
1.1
—
—
—
0
0
5
26
1.93
0.71
1.8
1.7
—
—
—
0
0
5
26
1.93
0.71
1.0
1.6
—
—
—
0
0
15
102
1.48
0.68
1.2
1.2
—
—
—
0
0
16
112
1.44
0.64
1.9
1.8
47.2
38.8
nmol/l
0.41
16
107
418
4049
1.14
0.63
5.7
4.6
1.9
2.2
mu/l
0.49
382
3665
79
687
1.18
0.63
1.4
1.5
—
—
—
0
0
130
1176
1.14
0.62
1.7
1.6
1.5
1.4
mmol/l
1.03
113
988
425
4124
1.14
0.62
33.2
11.6
79.9
81.2
ml/min/173m2
0.46
382
3347
37
300
1.25
0.60
1.2
1.2
101.5
162.8
iu/ml
0.69
12
119
65
749
0.85
0.58
2.6
3.0
0.8
0.8
ug/l
0.03
43
487
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
8
54
1.49
0.57
1.0
1.0
—
—
—
0
0
15
113
1.34
0.43
2.0
1.7
9.4
6.7
iu/l
—
6
40
5
32
1.57
0.42
1.2
1.5
0.8
1.0
g/l
—
5
32
409
3996
1.10
0.39
34.1
13.5
37.3
39.9
%
5.25
261
2912
11
81
1.37
0.36
2.0
1.9
169.4
217.1
pmol/l
0.61
11
76
43
477
0.89
0.26
2.7
2.3
—
—
—
0
0
419
4255
0.93
0.26
5.3
4.5
6.1
5.9
mmol/l
1.10
373
3872
39
432
0.90
0.24
2.6
2.1
—
—
—
0
0
5
38
1.32
0.23
1.2
1.2
—
94.4
—
0
5
30
267
1.13
0.22
1.4
1.3
—
42.9
—
0
14
0
10
0.00
0.21
0.0
1.0
—
23.4
—
0
10
8
103
0.77
0.21
1.5
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
397
4024
0.95
0.19
7.0
5.7
40.8
39.8
mmol/mol
1.05
364
3727
8
69
1.16
0.16
1.5
1.6
—
—
—
0
0
99
1024
0.96
0.12
3.3
4.2
21.5
21.6
%
0.02
44
482
23
211
1.09
0.11
2.9
2.0
—
—
—
0
0
12
105
1.15
0.11
2.8
1.7
—
—
—
0
0
10
114
0.87
0.09
1.4
1.4
—
—
—
0
0
13
145
0.89
0.09
4.3
1.7
—
—
—
0
0
53
550
0.96
0.07
4.8
4.6
30.9
31.7
%
0.18
40
358
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
8
95
0.84
0.06
1.3
1.4
—
—
—
0
0
15
139
1.08
0.05
1.3
1.4
—
—
—
0
0
24
229
1.05
0.04
1.3
1.3
—
—
—
0
0
492
4907
1.03
0.04
55.0
18.5
4.2
4.5
e12/l
21.47
479
4763
492
4908
1.03
0.03
55.4
18.7
126.2
135.6
g/l
30.67
487
4829
127
1283
0.99
0.03
4.5
4.9
4.8
2.5
ug/l
0.58
113
1143
24
231
1.04
0.03
1.0
1.0
—
—
—
0
0
13
128
1.02
0.00
2.1
1.5
—
—
—
0
0
17
168
1.01
0.00
1.3
1.5
—
—
—
0
0
26
259
1.00
0.00
3.0
2.1
—
—
—
0
0
5
55
0.91
0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
7
79
0.88
0.00
1.3
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_COMPLICATIO_FOLLOWI_INFUS_TRANSFU_THERAPE_INJEC – Complications following infusion, transfusion and therapeutic injection
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).